Join Vitti Long Haul’s innovative Phase 2 clinical trial investigating human Umbilical Cord Mesenchymal Stem Cell Exosomes. The VL-PX10 therapy aims to support immune regulation and promote cellular repair in long-haul conditions. Contribute to the advancement of regenerative medicine and help shape the future of healthcare innovation.
